Le Lézard
Classified in: Health, Science and technology, Business
Subject: PDT

EDETEK Launches CONFORMtm eClinical Version 5.1, Offering Comprehensive, Integrated Clinical Trial Management Solutions


PRINCETON, N.J., May 23, 2024 /PRNewswire/ -- EDETEK, a leading provider of innovative clinical trial solutions, is proud to announce the release of CONFORMtm eClinical Version 5.1. This latest version offers a fully integrated suite of components designed to streamline and enhance the clinical trial management process.

CONFORMtm eClinical Version 5.1 includes end-to-end, fully integrated components such as Electronic Data Capture (EDC), Randomization and Trial Supply Management (RTSM), Clinical Trial Management System (CTMS), electronic Trial Master File (eTMF), Pharmacovigilance/Safety (PV/Safety), electronic Diary (eDiary), electronic Patient-Reported Outcomes (ePRO), electronic Clinical Outcome Assessment (eCOA), ePayment, and eConsent. Additionally, it features advanced Study Management, central and risk-based monitoring, and data visualization modules.

These components provide sponsors with a turn-key solution driven by industry standards, ensuring comprehensive control over the entire study conduct. The integrated platform enhances quality, efficiency, and speed, offering significant cost savings and quick turn-around times.

With over 2,000 study experiences and more than 50 successful submissions, EDETEK has established a strong reputation in the industry. The company's partnerships with leading technology and service providers further strengthen its ability to deliver top-tier solutions for sponsors of all sizes.

"EDETEK's vision is to provide the best solution for sponsors, ensuring they have the tools and support needed to conduct successful clinical trials," said Jian Chen, CEO of EDETEK. "The release of CONFORMtm eClinical Version 5.1 is a testament to our commitment to innovation and excellence in the eClinical space."

Sponsors utilizing CONFORMtm eClinical Version 5.1 will benefit from a streamlined workflow, improved data quality, and enhanced study oversight, ensuring that clinical trials are conducted with the highest standards of accuracy and efficiency.

For more information about EDETEK and CONFORMtm eClinical Version 5.1, please visit www.edetek.com or contact [email protected].

About EDETEK

EDETEK is a premier provider of cutting-edge clinical trial solutions, committed to delivering high-quality, efficient, and cost-effective services. With a comprehensive portfolio of state-of-the-art products and a steadfast commitment to excellence, EDETEK empowers sponsors to achieve their clinical trial objectives seamlessly and successfully. Through innovation and unparalleled customer focus, EDETEK consistently drives the advancement of clinical research, ensuring optimal outcomes for every study.

Media Contact:
John F. Kouten
JFK Communications, Inc.
908-227-4714
[email protected]

SOURCE EDETEK, Inc.


These press releases may also interest you

at 07:00
Note: All times local Bürgenstock, Switzerland 9:15 a.m.        The Prime Minister will chair a break-out session at the Summit on Peace in Ukraine. Note for media: Official photographers11:00 a.m.      The Prime Minister will hold a media...

15 jun 2024
Vice President Kamala Harris, in a significant move, brought her economic opportunity tours to Atlanta to visit the 38th Conference of the 100 Black Men of America, Inc. This pivotal stop was to discuss economic empowerment with the audience,...

15 jun 2024
Note: All times local Bürgenstock, Switzerland 9:15 a.m.        The Prime Minister will chair a break-out session at the Summit on Peace in Ukraine. Note for media: Official photographers11:00 a.m.      The Prime Minister will hold a media...

15 jun 2024
Sweet Limited Partnership ("Sweet LP"), a limited partnership of which the sole general partner is Sweet GP Inc., a corporation owned and controlled by Michael Cooper, the President and Chief Responsible Officer of Dream Unlimited Corp. ("Dream"),...

15 jun 2024
Pomerantz LLP is investigating claims on behalf of investors of Petco Health and Wellness Company, Inc. ("Petco" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....

15 jun 2024
Pomerantz LLP is investigating claims on behalf of investors of GameStop Corp. ("GameStop" or the "Company") .  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.  ...



News published on and distributed by: